The National Expenditure on Civilian R&D increased by 1.1% in constant prices in 2020.
National expenditure on civilian R&D in 2020 amounted to NIS 76.2 billion - 5.4% of the GDP (5.1% in 2019).
The national expenditure on civilian R&D per capita in Israel, in 2020, amounted to 2,242.4 dollars (at current prices, in PPP terms of GDP), mainly due to a high concentration of development centers of multi-national companies in Israel.
In the Business sector, the R&D expenditure increased by 1.6%, at constant prices, in 2020, following increases of 14.5% in 2019 and 4.8% in 2018.
In 2019 51.5% of the expenditure on R&D was financed by Funds from Abroad and 38.1% by the Business sector.
In 2020, the share of grants for the advancement of general research (including GUF-Government University Funds) amounted to 53.2% and the share for advancement of industrial technology amounted to 33.6%.
